Remdesivir reduces duration of illness in patients with severe COVID-19, but what about patients with moderate disease? Read this EBM Focus article to learn more.
EBM Focus: Remdesivir for COVID-19 — Remain Skeptical
October 15, 2020
Climate change is associated with adverse health effects. Read this EBM Focus about a new study evaluating heat and air pollution on pregnancy outcomes.
EBM Focus: Hot Off the Press — Heat and Air Pollution Linked to Poor Pregnancy Outcomes
October 08, 2020
In this EBM Focus article, DynaMed editors examine a study finding a significant increase in Takotsubo syndrome (stress cardiomyopathy) during the COVID-19 pandemic.
EBM Focus: Collateral Damage of COVID-19 Pandemic Stress
October 01, 2020
In this EBM Focus article, DynaMed editors break down the new American Cancer Society cervical cancer screening recommendations.
EBM Focus: Bold New Recommendations for Cervical Cancer Screening
September 10, 2020
Here are five important points about antibody testing for diagnosis of COVID-19 from the EBM Focus team at DynaMed.
EBM Focus: Five Things You Should Know About COVID-19 Antibody Testing
August 05, 2020
COVID-19 represents the most recent example of health disparity among Black patients in America. This EBM Focus article discusses a study evaluating this inequity.
EBM Focus: Black Patients May Be at Increased Risk of COVID-19 Hospitalization and Death
July 08, 2020
Is remdesivir the miracle drug we need for COVID-19? Read DynaMed’s EBM Focus to find out.
EBM Focus: Remdesivir for COVID-19 May Speed Time to Recovery but Mortality Benefit Uncertain
June 22, 2020
What do we know about convalescent plasma therapy (CPT) for COVID-19? Read this new EBM Focus article to find out.
EBM Focus: Convalescent Plasma Therapy for COVID-19 — Hope or Hype?
June 11, 2020
Read about new open access clinical care content in EBSCO’s COVID-19 Information Portal from Jessica Bartell, MD, MS, Chief Medical Officer, Clinical Decision Support, EBSCO Clinical Decisions.
The Development of an Open Access COVID-19 Portal for Clinicians to Support Clinical Care
June 03, 2020
In this EBM Focus article, we delve into the hypothesis that ACE inhibitors could be associated with severe COVID-19, and a study that lets ACE inhibitors off the hook.
EBM Focus: It’s Not the ACE Inhibitors that are killing people with COVID-19
May 19, 2020
© 2020 EBSCO Information Services. All rights reserved